227 results on '"Marrouche, Nassir F."'
Search Results
2. HRS/EHRA/APHRS/LAHRS/ACC/AHA worldwide practice update for telehealth and arrhythmia monitoring during and after a pandemic
3. Wearables in cardiology: Here to stay
4. Transparent sharing of digital health data: A call to action
5. PO-03-120 ABLATION SCAR FORMATION IS SUPERIOR WITH THE KODEX-EPD MAPPING SYSTEM IN PERSISTENT ATRIAL FIBRILLATION PATIENTS
6. PO-01-099 EARLY REMODELING OF THE LEFT ATRIUM FOLLOWING CATHETER ABLATION OF PERSISTENT ATRIAL FIBRILLATION: THE IMPACT OF SUBSTRATE MODIFICATION IN DECAAF II
7. PO-01-199 ABLATION PARAMETERS AS PREDICTORS OF ATRIAL ARRHYTHMIA RECURRENCE AFTER PULMONARY VEIN ISOLATION ALONE IN PERSISTENT AF: A DECAAF II SUBSTUDY
8. CE-452780-1 LEFT ATRIAL VOLUME IS THE STRONGEST PREDICTOR OF ATRIAL ARRHYTHMIA RECURRENCE AFTER PULMONARY VEIN ISOLATION ALONE IN PERSISTENT AF: A DECAAF II SUBSTUDY
9. PO-02-094 ALL PULMONARY VEIN ISOLATION STRATEGIES ARE EQUALLY EFFECTIVE IN REDUCING THE RECURRENCE OF ATRIAL ARRHYTHMIAS
10. PO-02-168 ONE-YEAR OUTCOMES OF PULMONARY VEIN ISOLATION WITH A NOVEL CRYOBALLOON IN 325 PATIENTS: PRIMARY RESULTS OF THE FROZEN AF TRIAL
11. PO-03-093 EFFECT OF CATHETER ABLATION FOR ATRIAL FIBRILLATION ON LEFT ATRIAL FUNCTION AND LEFT VENTRICULAR DIASTOLIC FILLING
12. PO-01-169 CLINICAL APPLICATION OF A NOVEL 31MM CRYOBALLOON FOR PULMONARY VEIN ISOLATION FOR PAROXYSMAL ATRIAL FIBRILLATION: PROCEDURAL DATA FROM THE FIT ARM OF FROZEN AF
13. PO-01-097 HYPERLIPIDEMIA AS A PREDICTIVE RISK FACTOR OF ATRIAL ARRYTHMIA RECURRENCE FOLLOWING ABLATION: A DECAAF II SUBSTUDY
14. PO-05-200 GENDER DISPARITIES IN MANAGEMENT AND OUTCOMES OF ATRIAL FIBRILLATION IN A MODERN LOUISIANA COHORT
15. PO-03-202 WOMEN TRAINEES IN ELECTROPHYSIOLOGY AND THE EFFECT OF ROLE MODELS
16. CE-452778-4 SKIPPING ABLATION LESIONS DOES NOT AFFECT ATRIAL ARRHYTHMIA RECURRENCE AFTER PULMONARY VEIN ISOLATION IN PERSISTENT AF: A DECAAF II SUBSTUDY
17. PO-02-219 MODIFIABLE RISK FACTORS PREDICT THE RECURRENCE OF ARRHYTHMIA AFTER PERSISTENT AF ABLATION: ANALYSIS OF THE DECAAF II STUDY
18. PO-01-218 AFRICAN AMERICAN PATIENTS WITH AF AND OBESITY HAVE HIGHER COMORBIDITIES AND MORTALITY RATES THAN THEIR WHITE COUNTERPARTS
19. PO-696-03 INDEX ATRIAL MYOPATHY CORRELATES WITH ATRIAL FIBRILLATION BURDEN POST ABLATION INDEPENDENT FROM ABLATION-INDUCED SCAR
20. PO-697-05 COMPREHENSIVE EVALUATION OF ATRIAL FIBRILLATION RECURRENCE POST CATHER ABLATION THROUGH TEMPORAL PATTERNS
21. PO-699-03 ISCHEMIC STROKE RISK CORRELATES WITH DEGREE OF LEFT ATRIAL FIBROSIS IN ATRIAL FIBRILLATION PATIENTS
22. PO-689-05 PREDICTORS OF ARRHYTHMIA OCCURRENCE IN HOSPITALIZED COVID-19 PATIENTS
23. PO-703-02 DIGITAL HEALTH DEVICE DEMONSTRATES THE LONG-TERM IMPACT OF COVID-19 ON THE CARDIOVASCULAR AND AUTONOMIC SYSTEM
24. PO-697-04 WORSE ABLATION-INDUCED SCAR FORMATION ON FIBROTIC TISSUE: A SUB ANALYSIS FROM THE DECAAF II
25. PO-624-06 THE DIELECTRIC IMAGING SYSTEM IS SUPERIOR TO FLUOROSCOPY IN PREVENTING ATRIAL FIBRILLATION RECURRENCE AFTER CRYOABLATION
26. PO-05-125 BODY MASS INDEX AS A DETERMINANT OF SCAR FORMATION POST-AF ABLATION: INSIGHTS FROM THE DECAAF II STUDY
27. PO-05-126 SUSTAINED ATRIAL FIBRILLATION BURDEN IN THE BLANKING PERIOD IS ASSOCIATED WITH A HIGH RISK OF RECURRENCE AFTER CATHETER ABLATION
28. PO-04-101 IMPACT OF FOOD DESERT RESIDENCE ON STROKE AND HOSPITALIZATION IN PATIENTS WITH ATRIAL FIBRILLATION
29. PO-04-085 AN AI MODEL PREDICTING AF RECURRENCE POST-ABLATION USING DAY-1 POST-OP ECG STRIP
30. PO-04-083 QUANTIFYING ENTROPY IN ATRIAL MYOPATHY TO ASSESS THE ROLE OF CHAOS IN FIBROSIS DISTRIBUTION
31. PO-04-143 A PRAGMATIC SCORE FOR BASELINE ATRIAL FIBROSIS PREVALENCE IN PERSISTENT ATRIAL FIBRILLATION PATIENTS UNDERGOING ABLATION
32. PO-04-142 BASELINE NATRIURETIC PEPTIDES IS A STRONG MARKER OF ATRIAL REMODELING IN NON-HEART FAILURE PATIENTS WITH PERSISTENT AF UNDERGOING PULMONARY VEIN ISOLATION
33. PO-03-024 CLUSTER ANALYSIS TO IDENTIFY PATTERNS OF FIBROSIS DISTRIBUTION AMONG PERSISTENT ATRIAL FIBRILLATION PATIENTS WITH HIGH LEFT ATRIAL VOLUME
34. PO-03-023 USING MACHINE LEARNING-BASED METHOD TO REDEFINE THE SEVERITY OF ATRIAL FIBRILLATION
35. PO-03-090 IMPACT OF ABLATION ENERGY AND SUBSTRATE MODIFICATION ON REGRESSION FROM PERSISTENT ATRIAL FIBRILLATION TO PAROXYSMAL ATRIAL FIBRILLATION
36. PO-03-132 DIRECT CATHETER ABLATION VERSUS CATHETER ABLATION POST ANTIARRHYTHMIC DRUG THERAPY FOR PERSISTENT ATRIAL FIBRILLATION: EFFECT ON ARRHYTHMIA RECURRENCE, AF BURDEN, EARLY LEFT ATRIUM REMODELING AND QUALITY OF LIFE
37. PO-03-131 AGE-RELATED LEFT ATRIAL REMODELING AND EFFICACY OF CATHETER ABLATION OF PERSISTENT ATRIAL FIBRILLATION
38. PO-03-129 LESSONS LEARNED FROM VARIATION IN RADIOFREQUENCY ENERGY DELIVERY SETTINGS IN A MULTICENTER RANDOMIZED TRIAL: IMPORTANCE OF POWER AND DURATION
39. PO-01-057 WARFARIN USE AND PROGRESSION OF ATRIAL FIBRILLATION: A RETROSPECTIVE ANALYSIS IN A COHORT FROM THE REACHNET DATABASE
40. AB-482902-004 FEMALE SEX IS THE STRONGEST PREDICTOR OF AF RECURRENCE AFTER ABLATION OF PERSISTENT ATRIAL FIBRILLATION: INSIGHTS FROM DECAAF II
41. MP-483498-008 RISK STRATIFICATION FOR POST-AF ABLATION ARRHYTHMIA RECCURRENCE - DECAAF II SUBANALYSIS
42. B-PO02-070 RACIAL AND SOCIOECONOMIC DISPARITIES IN PATIENTS WITH ATRIAL FIBRILLATION
43. B-PO02-183 MOBILE ELECTROCARDIOGRAM SIGNAL QUALITY ASSESSMENT AND ENHANCEMENT WITH ARTIFICIAL INTELLIGENCE
44. B-PO05-142 ATRIAL FIBRILLATION PATIENT WITH LOW CHA2DS2VASC SCORE MAY STILL BENEFIT FROM ORAL ANTICOAGULATION THERAPY FOR ISCHEMIC STROKE PREVENTION: THE NEED TO REFINE STROKE RISK ASSESSMENT SCORES
45. B-PO04-116 ESOPHAGEAL TEMPERATURE DURING ATRIAL FIBRILLATION ABLATION POORLY PREDICTS ESOPHAGEAL INJURY: AN OBSERVATIONAL STUDY
46. B-PO05-016 SETTLING THE CATHETER ABLATION DISPUTE: ABLATION PARAMETERS DO NOT MATTER
47. B-PO02-182 DISPARITIES IN WEARABLE HEALTH DEVICE AND TELEMEDICINE UNDERSTANDING AND UTILIZATION AMONGST CARDIOLOGY PATIENTS IN NEW ORLEANS
48. Temporal left atrial lesion formation after ablation of atrial fibrillation
49. Consumer-tech-provider co-doctoring in the digital age: A neglected TRIAD
50. MP-453081-3 PHENOTYPES OF PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION AND RISK OF ARRHYTHMIA RECURRENCE - A DECAAF II SUBANALYSIS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.